Loading clinical trials...

Role of Skin Cleansing and Prophylactic Antibiotic in Preventing Infectious Morbidity After Cesarean Section Delivery | Clinical Trials | Clareo Health

Back to search

UNKNOWN

Role of Skin Cleansing and Prophylactic Antibiotic in Preventing Infectious Morbidity After Cesarean Section Delivery

NCT03007706•Raghda Gamal Mohamed

View on ClinicalTrials.gov

Summary

This study aims to determine the effectiveness of skin cleansing and prophylactic antibiotics given to women undergoing a cesarean section for reducing the incidence of postpartum infectious morbidity and to assess potential maternal adverse effects and any impact on the infant.

Eligibility

Age

18 - 45 years

Sex

FEMALE

Healthy Volunteers

Yes

Inclusion Criteria

•1. Women undergoing cesarean delivery, both elective and non-elective.
•2. Rupture of membranes and labor contractions will be allowed.

Exclusion Criteria

•1. Unknown outcome from the patient.
•2. Refusing to participate in the study from the admission conse
•3. Allergy to antibiotics.
•4. Any visible infection.

Key Dates

Start Date

January 1, 2017

Primary Completion Date

June 1, 2017

Completion Date

October 1, 2017

Last Updated

January 4, 2017

Enrollment

200

ESTIMATED participants

Conditions

Postpartum Infectious Morbidity in Cesarean Section Delivery

Interventions

Women undergo cesarean section delivery

PROCEDURE